A 3 year PhD fellowship is available in the Group of Structural Biology and Drug Development (Luecke
group) at the Centre for Molecular Medicine Norway (NCMM), University of Oslo (UiO).
The Group for Structural Biology and Drug Development investigates medically relevant proteins and protein complexes using biophysical, biochemical and structural approaches. The projects
aim at understanding structure-function relationships with an emphasis on drug discovery. We employ a variety of biochemical and biophysical techniques (x-ray crystallography, single particle cryo electron microscopy, DSF, ITC, SPR, HDX-MS, SAXS, molecular
dynamics simulations etc.). Externally funded projects include inhibitor discovery targeting the Helicobacter pylori pH acclimation system (a pH-gated urea channel and a cytoplasmic urease), and discovery of compounds that reactivate p53 cancer mutants in
vitro and in vivo. Additional projects are available.
The PhD student will also benefit from career development programs offered both at UiO, the Norwegian BioCat initiative as
well as the Nordic EMBL network of the Centre for Molecular Medicine, Norway.
Online application required, deadline 31 Mar 2019:
https://www.jobbnorge.no/en/available-jobs/job/164159/two-2-postdoctoral-fellowships-in-structural-biology-and-drug-development
--
Prof. Hartmut Luecke
Structural Biology and Drug Discovery Group
Norwegian Centre for Molecular Medicine (NCMM), Nordic EMBL Partnership
and Institute of Clinical Medicine, University of Oslo
Dept. of Medical Biochemistry, Oslo University Hospital
Oslo, Norway
To unsubscribe from the CCPEM list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCPEM&A=1